These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

303 related items for PubMed ID: 28351169

  • 1. Pharmacotherapeutic agents in the treatment of methamphetamine dependence.
    Morley KC, Cornish JL, Faingold A, Wood K, Haber PS.
    Expert Opin Investig Drugs; 2017 May; 26(5):563-578. PubMed ID: 28351169
    [Abstract] [Full Text] [Related]

  • 2. Pharmacological treatments for methamphetamine addiction: current status and future directions.
    Ballester J, Valentine G, Sofuoglu M.
    Expert Rev Clin Pharmacol; 2017 Mar; 10(3):305-314. PubMed ID: 27927042
    [Abstract] [Full Text] [Related]

  • 3. Pharmacological Treatment of Methamphetamine/Amphetamine Dependence: A Systematic Review.
    Siefried KJ, Acheson LS, Lintzeris N, Ezard N.
    CNS Drugs; 2020 Apr; 34(4):337-365. PubMed ID: 32185696
    [Abstract] [Full Text] [Related]

  • 4. Pharmacotherapeutic strategies for methamphetamine use disorder: mind the subgroups.
    Soares E, Pereira FC.
    Expert Opin Pharmacother; 2019 Dec; 20(18):2273-2293. PubMed ID: 31671001
    [Abstract] [Full Text] [Related]

  • 5. Clinical effects and management of methamphetamine abuse.
    Romanelli F, Smith KM.
    Pharmacotherapy; 2006 Aug; 26(8):1148-56. PubMed ID: 16863490
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Quite a lot of smoke but very limited fire--the use of methamphetamine in Europe.
    Griffiths P, Mravcik V, Lopez D, Klempova D.
    Drug Alcohol Rev; 2008 May; 27(3):236-42. PubMed ID: 18368604
    [Abstract] [Full Text] [Related]

  • 8. [Current data on methamphetamine].
    Cottencin O, Rolland B, Guardia D, Karila L.
    Rev Prat; 2012 May; 62(5):679-81. PubMed ID: 22730802
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Subjective and physiological effects of acute intranasal methamphetamine during d-amphetamine maintenance.
    Rush CR, Stoops WW, Lile JA, Glaser PE, Hays LR.
    Psychopharmacology (Berl); 2011 Apr; 214(3):665-74. PubMed ID: 21072503
    [Abstract] [Full Text] [Related]

  • 15. Epidemiology and public health Consequences of methamphetamine use in California's Central Valley.
    Gibson DR, Leamon MH, Flynn N.
    J Psychoactive Drugs; 2002 Apr; 34(3):313-9. PubMed ID: 12422943
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. DARK Classics in Chemical Neuroscience: Methamphetamine.
    Abbruscato TJ, Trippier PC.
    ACS Chem Neurosci; 2018 Oct 17; 9(10):2373-2378. PubMed ID: 29602278
    [Abstract] [Full Text] [Related]

  • 18. The epidemiology of methamphetamine use and harm in Australia.
    Degenhardt L, Roxburgh A, Black E, Bruno R, Campbell G, Kinner S, Fetherston J.
    Drug Alcohol Rev; 2008 May 17; 27(3):243-52. PubMed ID: 18368605
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.